Tofogliflozin, a novel and selective SGLT2 inhibitor improves glycemic control and lowers body weight in patients with type 2 diabetes mellitus inadequately. Reference standards of Tofogliflozin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Tofogliflozin-d5 [catalogue_number] => PA STI 083570 [category_ids] => ,80,71,81,78,70,82,98, [chemical_name] => [weight] => 391.47 [form] => C22H21D5O6 [cas] => NA [pslug] => tofogliflozin-d5-pasti083570 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA STI 083570
CAS :
Molecular Formula : C22H21D5O6
Molecular Weight : 391.47
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
